Ispire Technology (ISPR, Financial) has taken a significant step forward in vapor safety and compliance by partnering with IKE Tech to submit a Pre-Market Tobacco Product Application (PMTA) to the FDA. The application involves a Bluetooth Low Energy (BLE) System-on-a-Chip designed for use in Electronic Nicotine Delivery Systems (ENDS). This groundbreaking technology uses blockchain to provide continuous, real-time age verification, beyond the traditional one-time purchase check.
The BLE chip ensures secure and universal integration across all ENDS devices and requests an expedited FDA review. It demonstrated 100% effectiveness in preventing access by underage users and full accuracy in demographic checks, while maintaining a user error rate of less than 1%. Additionally, 91% of users expressed satisfaction with the app's ease of use. This submission follows a pre-PMTA meeting with the FDA in late 2024, where regulatory support for evaluating component-based PMTAs was confirmed.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 1 analysts, the average target price for Ispire Technology Inc (ISPR, Financial) is $9.00 with a high estimate of $9.00 and a low estimate of $9.00. The average target implies an upside of 226.09% from the current price of $2.76. More detailed estimate data can be found on the Ispire Technology Inc (ISPR) Forecast page.
Based on the consensus recommendation from 1 brokerage firms, Ispire Technology Inc's (ISPR, Financial) average brokerage recommendation is currently 2.0, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
